{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:41:31Z","timestamp":1788309691188,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jpeds.2009.09.008","type":"journal-article","created":{"date-parts":[[2009,10,28]],"date-time":"2009-10-28T04:14:20Z","timestamp":1256703260000},"page":"302-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Favorable Outcome of Juvenile Dermatomyositis Treated without Systemic Corticosteroids"],"prefix":"10.1016","volume":"156","author":[{"given":"Deborah M.","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. April","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Eichenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa F.","family":"Imundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2009.09.008_bib1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","article-title":"Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification","volume":"103","author":"Bowyer","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2009.09.008_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00128072-200204050-00004","article-title":"Juvenile dermatomyositis: recognition and treatment","volume":"4","author":"Reed","year":"2002","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jpeds.2009.09.008_bib3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.1780351006","article-title":"Methotrexate treatment of recalcitrant childhood dermatomyositis","volume":"35","author":"Miller","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2009.09.008_bib4","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2009.09.008_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s100670050032","article-title":"Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate","volume":"19","author":"Al-Mayouf","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jpeds.2009.09.008_bib6","first-page":"1424","article-title":"Cyclosporin a therapy in refractory juvenile dermatomyositis: experience and longterm followup of 6 cases","volume":"23","author":"Zeller","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpeds.2009.09.008_bib7","first-page":"2436","article-title":"Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis","volume":"24","author":"Reiff","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpeds.2009.09.008_bib8","first-page":"1545","article-title":"Adjunctive use of hydroxychloroquine in childhood dermatomyositis","volume":"16","author":"Olson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpeds.2009.09.008_bib9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0190-9622(84)80263-7","article-title":"Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine","volume":"10","author":"Woo","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpeds.2009.09.008_bib10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(89)92456-2","article-title":"Cyclosporin in juvenile dermatomyositis","volume":"1","author":"Heckmatt","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2009.09.008_bib11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2009.09.008_bib12","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","article-title":"Intravenous immunoglobulin in autoimmune neuromuscular diseases","volume":"291","author":"Dalakas","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2009.09.008_bib13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1136\/ard.2006.058644","article-title":"Limited effects of high-dose intravenous immunoglobulin (IVIg) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies","volume":"66","author":"Barbasso Helmers","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jpeds.2009.09.008_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9343(91)90010-U","article-title":"Treatment of dermatomyositis with intravenous gammaglobulin","volume":"91","author":"Lang","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jpeds.2009.09.008_bib15","first-page":"1979","article-title":"[Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis]","volume":"137","author":"Breems","year":"1993","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.jpeds.2009.09.008_bib16","first-page":"111","article-title":"Intravenous immunoglobulin therapy in juvenile dermatomyositis","volume":"38","author":"Tsai","year":"1997","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"10.1016\/j.jpeds.2009.09.008_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02230347","article-title":"Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis","volume":"15","author":"Galeazzi","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jpeds.2009.09.008_bib18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1442-200x.1999.01132.x","article-title":"Intravenous immunoglobulin treatment in a girl with juvenile dermatomyositis","volume":"41","author":"Kokori","year":"1999","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2009.09.008_bib19","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1007\/BF01540893","article-title":"Use of intravenous immune globulin in the therapy of children with rheumatological diseases","volume":"15","author":"Roifman","year":"1995","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jpeds.2009.09.008_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","article-title":"Intravenous immunoglobulin in juvenile dermatomyositis: four year review of nine cases","volume":"72","author":"Sansome","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2009.09.008_bib21","first-page":"2498","article-title":"Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety","volume":"27","author":"Al-Mayouf","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpeds.2009.09.008_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2009.09.008_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2009.09.008_bib24","first-page":"2031","article-title":"Juvenile amyopathic dermatomyositis: results of a case finding descriptive survey","volume":"27","author":"Plamondon","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpeds.2009.09.008_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.1780300312","article-title":"Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis","volume":"30","author":"Laxer","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2009.09.008_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1542\/peds.100.3.391","article-title":"Juvenile dermatomyositis presenting with rash alone","volume":"100","author":"Eisenstein","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2009.09.008_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","article-title":"Duration of illness is an important variable for untreated children with juvenile dermatomyositis","volume":"148","author":"Pachman","year":"2006","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jpeds.2009.09.008_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","article-title":"Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis","volume":"43","author":"Huber","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2009.09.008_bib29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","article-title":"Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes","volume":"28","author":"Ramanan","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jpeds.2009.09.008_bib30","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1542\/peds.2007-1218","article-title":"Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content","volume":"121","author":"Manlhiot","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2009.09.008_bib31","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.20179","article-title":"Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies","volume":"50","author":"Huber","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2009.09.008_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/art.23248","volume":"59","author":"Ruperto","year":"2008","journal-title":"Arthritis Rheum"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347609008762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347609008762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:52:52Z","timestamp":1758358372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347609008762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0022347609008762"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2009.09.008","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Favorable Outcome of Juvenile Dermatomyositis Treated without Systemic Corticosteroids","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2009.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}